Ruf, Peter
1TRION Research GmbH, Martinsried, Germany and
4 papers on CoChatORCID 0000-0001-8180-1501
Most cited papers
- Verified
Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody
Ruf, P., & Lindhofer, H. (2001) · Blood
Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Cited by 174
- Verified
The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
Jäger, M., Schoberth, A., Ruf, P., Hess, J., & Lindhofer, H. (2009) · Cancer Research
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 94
- Verified
Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels
Stanglmaier, M., Faltin, M., Ruf, P., Bodenhausen, A., Schröder, P., & Lindhofer, H. (2008) · International Journal of Cancer
Monoclonal and Polyclonal Antibodies ResearchLymphoma Diagnosis and Treatment
Cited by 66
- Verified
Two new trifunctional antibodies for the therapy of human malignant melanoma
Ruf, P., Jäger, M., Ellwart, J., Wosch, S., Kusterer, E., & Lindhofer, H. (2004) · International Journal of Cancer
Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Cited by 52
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free